Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides

By Dias N.   Stein C.A.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. : 263-269

Elsevier

Access to resources Recommend Favorite

Physicochemical and biological characterisation of an antisense oligonucleotide targeted against the bcl-2 mRNA complexed with cationic-hydrophilic copolymers

By Read M.L.   Dash P.R.   Clark A.   Howard K.A.   Oupicky D.   Toncheva V.   Alpar H.O.   Schacht E.H.   Ulbrich K.   Seymour L.W.  

European Journal of Pharmaceutical Sciences, Vol. 10, Iss. 3, 2000-05 ,pp. : 169-177

Elsevier

Access to resources Recommend Favorite

Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2

By Weecharangsan Wanlop   Lee Robert J.  

Drug Delivery, Vol. 19, Iss. 6, 2012-08 ,pp. : 292-297

Informa Healthcare

Access to resources Recommend Favorite

Bcl-2-targeted cancer therapeutics

By Khorchid Amani   Beauparlant Pierre  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 805-818

Informa Healthcare

Access to resources Recommend Favorite

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

By Maksimenko Andrei   Malvy Claude  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 825-830

Informa Healthcare

Access to resources Recommend Favorite